Keyphrases
Angiogenic Factors
25%
Anti-VEGF Antibody
25%
Anti-VEGF Therapy
100%
Antiangiogenic Agents
25%
Clinical Centers
25%
Combination Strategy
25%
Effect Mechanism
100%
Endothelial Cell Proliferation
25%
Escape Mechanism
100%
Glioma Therapy
100%
Novel Treatments
25%
Optimal Target
25%
Phase III Clinical Trial
25%
Proangiogenic Growth Factors
25%
Prognosis Treatment
25%
Treatment Effect
100%
Treatment Regimen
25%
Vascular Tumor
25%
Medicine and Dentistry
Angiogenic Factor
25%
Antiangiogenic
50%
Antiangiogenic Therapy
100%
Bevacizumab
25%
Cell Proliferation
25%
Clinical Trial
50%
Endothelial Cell
25%
Ganglioglioma
75%
Glioblastoma
100%
Glioma Cell
25%
Growth Factor
25%
Monotherapy
25%
Neoplasm
75%
Treatment Effect
100%
Vasculotropin
100%
Pharmacology, Toxicology and Pharmaceutical Science
Angiogenic Factor
25%
Antiangiogenic
50%
Antiangiogenic Therapy
100%
Bevacizumab
25%
Chemotherapy
50%
Clinical Trial
50%
Glioblastoma
100%
Growth Factor
25%
Monotherapy
25%
Neoplasm
75%
Vasculotropin
100%
Neuroscience
Angiogenic Factor
33%
Bevacizumab
33%
Cell Proliferation
33%
Glioblastoma Multiforme
100%
Growth Factor
33%
Vascular Endothelial Growth Factor
100%
Vasculotropin Antibody
33%